Keros Therapeutics Shares Are Trading Higher After the Company Was Selected as Part of a Deal to Boost an Oncology Pipeline With Eltritercept.
Keros Therapeutics Shares Are Trading Higher After the Company Was Selected as Part of a Deal to Boost an Oncology Pipeline With Eltritercept.
Keros therapeutics的股票在公司被選中作爲一項交易的一部分，以提升與Eltritercept合作的腫瘤學管道後，交易價格上漲。
Keros Therapeutics Shares Are Trading Higher After the Company Was Selected as Part of a Deal to Boost an Oncology Pipeline With Eltritercept.
keros therapeutics的股票在公司被選中作爲提升與Eltritercept的腫瘤治療管道的一部分後交易上漲。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。